Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Secondary hyperparathyroidism is a common complication of end-stage renal disease requiring long-term dialysis.
• Histological patterns include diffuse and nodular hyperplasia, with the latter indicating autonomous cell proliferation.
• The molecular mechanisms driving advanced secondary hyperparathyroidism remain incompletely understood, limiting therapeutic options.

Purpose of the Study:

• To investigate the role of CCAAT enhancer binding protein beta (C/EBPβ) in the pathogenesis of secondary hyperparathyroidism.
• To explore the molecular mechanisms underlying parathyroid cell proliferation in nodular hyperplasia.

Main Methods:

• Immunohistochemical analysis of C/EBPβ, cyclin D1, and Ki-67 in normal, diffuse hyperplastic, and nodular hyperplastic parathyroid glands.
• Immunofluorescent double staining to assess coexpression of phosphorylated C/EBPβ and Ras.
• Quantitative analysis of cell proliferation markers.

Main Results:

• C/EBPβ staining intensity was significantly increased in nodular hyperplasia compared to normal and diffuse hyperplastic tissues.
• Nodular hyperplasia showed higher cyclin D1 and Ki-67 labeling indices, indicating increased cell proliferation.
• Coexpression of phosphorylated C/EBPβ and cytoplasmic Ras was observed in nodular hyperplasia, suggesting activation of the Ras/MAPK pathway.

Conclusions:

• Upregulated and phosphorylated C/EBPβ interacts with the Ras/MAPK pathway in nodular parathyroid hyperplasia, driving autonomous cell proliferation.
• This mechanism resembles that of parathyroid tumorigenesis.
• C/EBPβ represents a potential therapeutic target for advanced secondary hyperparathyroidism and parathyroid tumor growth.